SCMSJournal.com

Highlights of Skin Disease Education Foundation’s 38th Annual Hawaii Dermatology Seminar

Jun

2014

Vol. 33. No. 4

Introduction

This supplement provides a concise yet thorough summation of presentations at the seminar. Leading authorities in the management of psoriasis, skin cancer, and rejuvenation treatment share their expertise and insights that dermatologists will find readily applicable to clinical practice.

Introduction

Craig L. Leonardi, MD

Dermatology has evolved into one of the most dynamic specialties in medicine. Advances in cellular and molecular biology have translated into clinical progress in the management of multiple conditions that dermatologists treat

The Role of TNF Inhibitors in Psoriatic Disease

Jeffrey M Sobell, MD | Brian F Mandell, MD, PhD

The introduction of tumor necrosis factor-α inhibitors marked the beginning of the biologic era of psoriasis therapy.

Therapeutic Development in Psoriasis

Craig L. Leonardi, MD | Jeffrey M Sobell, MD

Advances in molecular biology have provided the basis for development of new therapeutic approaches to psoriasis

Data on the Safety of Psoriasis Therapies

Craig L. Leonardi, MD

Safety remains paramount to the clinical utility of a therapy.

New Therapeutic Options for Actinic Keratosis and Basal Cell Carcinoma

James E Sligh, Jr, MD, PhD

Actinic keratosis (AK) is a common premalignant skin lesion that is frequently treated by cryosurgery.